| 1 |
Cooper LT Jr. Myocarditis. N Engl J Med. 2009; 360(15):1526-38.
doi: 10.1056/NEJMra0800028
|
| 2 |
Mason JW, O’Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med. 1995; 333(5):269-75.
doi: 10.1056/NEJM199508033330501
|
| 3 |
Ammirati E, Cipriani M, Moro C, Raineri C, Pini D, Sormani P, et al. Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: multicenter Lombardy registry. Circulation. 2018; 138(11):1088-99.
doi: 10.1161/CIRCULATIONAHA.118.035319
pmid: 29764898
|
| 4 |
Pinamonti B, Alberti E, Cigalotto A, Dreas L, Salvi A, Silvestri F, et al. Echocardiographic findings in myocarditis. Am J Cardiol. 1988; 62(4):285-91.
pmid: 3400607
|
| 5 |
McCarthy RE 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. 2000; 342(10):690-5.
doi: 10.1056/NEJM200003093421003
|
| 6 |
Mendes LA, Dec GW, Picard MH, Palacios IF, Newell J, Davidoff R. Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J. 1994; 128(2):301-7.
pmid: 8037097
|
), Alan Lucerna2, Henry Schuitema3
